Ipca Laboratories Ltd.
|
Income Statement
|
|
You can view the
Income Statement
for the last 5 years.
Market Cap. (Rs.)
|
33228.91 Cr.
|
P/BV
|
5.69
|
Book Value (Rs.)
|
230.27
|
52 Week High/Low (Rs.)
|
1375/670
|
FV/ML
|
1/1
|
P/E(X)
|
70.50
|
Bookclosure
|
22/11/2023
|
EPS (Rs.)
|
18.58
|
Div Yield (%)
|
0.31
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 6206.85 | 5766.46 | 5366.00 | 4588.38 | 3719.68 |
Other Operating Revenues | 37.47 | 63.33 | 53.99 | 60.33 | 53.50 |
Total Operating Revenues | 6244.32 | 5829.79 | 5419.99 | 4648.71 | 3773.18 |
| | | | | |
Other Income | 125.62 | 66.57 | 62.84 | 67.00 | 57.68 |
Total Revenue | 6369.94 | 5896.36 | 5482.83 | 4715.71 | 3830.86 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 1708.65 | 1664.20 | 1597.14 | 1460.37 | 1106.08 |
Purchase Of Stock-In Trade | 497.19 | 480.30 | 325.95 | 359.88 | 249.07 |
Changes In Inventories Of FG,WIP And Stock-In Trade | 100.67 | -129.65 | -194.79 | -176.12 | -115.42 |
Employee Benefit Expenses | 1287.64 | 1177.39 | 1013.57 | 921.23 | 787.40 |
Finance Costs | 45.54 | 7.69 | 9.04 | 16.50 | 18.87 |
Depreciation And Amortisation Expenses | 261.56 | 232.42 | 209.17 | 210.50 | 182.42 |
Other Expenses | 1723.40 | 1328.29 | 1133.77 | 1176.65 | 1054.17 |
Total Expenses | 5624.65 | 4760.64 | 4093.85 | 3969.01 | 3282.59 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 745.29 | 1135.72 | 1388.98 | 746.70 | 548.27 |
| | | | | |
Profit/Loss Before Tax | 745.29 | 1135.72 | 1388.98 | 746.70 | 548.27 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 230.14 | 207.01 | 248.65 | 140.59 | 121.81 |
Deferred Tax | 23.00 | 17.26 | -8.50 | -5.78 | -12.13 |
Tax For Earlier Years | 0.22 | 0.50 | -0.01 | 0.52 | -5.44 |
Total Tax Expenses | 253.36 | 224.77 | 240.14 | 135.33 | 104.24 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 491.93 | 910.95 | 1148.84 | 611.37 | 444.03 |
| | | | | |
Profit/Loss From Continuing Operations | 491.93 | 910.95 | 1148.84 | 611.37 | 444.03 |
| | | | | |
Profit/Loss For The Period | 491.93 | 910.95 | 1148.84 | 611.37 | 444.03 |
| | | | | |
Minority Interest | -7.67 | -5.71 | -1.13 | 2.76 | 2.61 |
Share Of Profit/Loss Of Associates | -12.94 | -21.16 | -7.70 | -7.81 | -1.81 |
Consolidated Profit/Loss After MI And Associates | 471.32 | 884.08 | 1140.01 | 606.32 | 444.83 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 18.58 | 34.85 | 45.01 | 47.77 | 35.01 |
Diluted EPS (Rs.) | 18.58 | 34.85 | 45.01 | 47.73 | 35.01 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 101.48 | 101.48 | 101.48 | 101.08 | 12.64 |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 20.77 | 2.60 |